Zeynep Eras
Research Subjects
Zeynep Eras has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Fuat Emre Canpolat
Department of Neonatology, NICU, University of Health Sciences, Ankara Bilkent City Hospital, Bilkent/Çankaya, Ankara, Turkey
3 shared publications - Gülsüm Kadıoğlu Şimşek
Department of Neonatology University of Health Sciences, Ankara Bilkent City Hospital Ankara Çankaya Turkey
3 shared publications - Hayriye Gözde Kanmaz Kutman
Department of Neonatology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara 06800, Turkey
3 shared publications - Mehmet Buyuktiryaki
İstanbul Medipol Üniversitesi Tıp Fakültesi
3 shared publications - Esin Okman
Department of Pediatrics, Bilkent City Hospital, Ankara 06800, Türkiye
2 shared publications - Sultan Kavuncuoglu
Clinic of Pediatrics, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Turkey
2 shared publications
Latest Publications
- 12 January 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (3) , 451-456
Risk Factors in Addition to Short and Long‐Term Outcomes With Thin Catheter Surfactant Administration Failure in Preterm Infants: A Retrospective Analysis
Objective: To evaluate the incidence of thin catheter surfactant administration (TCA) failure and compare short and long‐term neonatal outcomes who failed TCA or did not.Design: Single‐center retrospective cohort study. Infants between 25 and 30 weeks of gestational age with respiratory distress syndrome and receiving 200 mg/kg poractant alfa via thin catheter administration were included. TCA failure was defined as the need for early mechanical ventilation (< 72 h). Infants were divided into two groups those who failed TCA or those who did not.Results: The TCA failure rate was 24.6%. Initial oxygen requirement (0.39% vs. 0.36%) and the number of small for gestational age infants were significantly higher in the TCA failure group (15% vs. 7.9%). Infants who failed TCA had a higher pneumothorax (6.7% vs. 1.1%, p = 0.03), BPD (15% vs.5.5%, p = 0.02), late‐onset sepsis (36.7% vs. 18%, p = 0.04), retinopathy of prematurity rates (11.7% vs. 3.3%, p = 0.02) and an increased duration of respiratory support. However, Bayley Scales of Infant Development II scores were comparable between groups at 18 and 26 months of corrected age.Conclusion: Infants who fail TCA are at increased risk for short‐term complications despite favourable long‐term neurodevelopmental outcomes. Identifying infants at risk of TCA failure may help early prevention of morbidities and individualise their management.
- 12 January 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (3) , 451-456
Risk Factors in Addition to Short and Long‐Term Outcomes With Thin Catheter Surfactant Administration Failure in Preterm Infants: A Retrospective Analysis
Objective: To evaluate the incidence of thin catheter surfactant administration (TCA) failure and compare short and long‐term neonatal outcomes who failed TCA or did not.Design: Single‐center retrospective cohort study. Infants between 25 and 30 weeks of gestational age with respiratory distress syndrome and receiving 200 mg/kg poractant alfa via thin catheter administration were included. TCA failure was defined as the need for early mechanical ventilation (< 72 h). Infants were divided into two groups those who failed TCA or those who did not.Results: The TCA failure rate was 24.6%. Initial oxygen requirement (0.39% vs. 0.36%) and the number of small for gestational age infants were significantly higher in the TCA failure group (15% vs. 7.9%). Infants who failed TCA had a higher pneumothorax (6.7% vs. 1.1%, p = 0.03), BPD (15% vs.5.5%, p = 0.02), late‐onset sepsis (36.7% vs. 18%, p = 0.04), retinopathy of prematurity rates (11.7% vs. 3.3%, p = 0.02) and an increased duration of respiratory support. However, Bayley Scales of Infant Development II scores were comparable between groups at 18 and 26 months of corrected age.Conclusion: Infants who fail TCA are at increased risk for short‐term complications despite favourable long‐term neurodevelopmental outcomes. Identifying infants at risk of TCA failure may help early prevention of morbidities and individualise their management.
- 19 December 2022
- Published by Galenos Yayinevi in Güncel Pediatri
- Vol. 20 (3) , 331-338
Being Small for Gestational Age Affect Neurodevelopmental Outcomes in Very Preterm Infants
- 19 December 2022
- Published by Galenos Yayinevi in Güncel Pediatri
- Vol. 20 (3) , 331-338
Being Small for Gestational Age Affect Neurodevelopmental Outcomes in Very Preterm Infants
- 1 January 2021
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 59 (1) , 37-42
Neonatal Prognosis and Outcomes in Adolescent Pregnancies
- 1 January 2021
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 59 (1) , 37-42
Neonatal Prognosis and Outcomes in Adolescent Pregnancies
- 18 December 2019
- Published by Springer Nature in Child's Nervous System
- Vol. 36 (6) , 1231-1237
Developmental outcomes of very low birthweight infants with non-hemorrhagic ventricular dilatations and the relationships thereof with absolute brain volumes measured via two-dimensional ultrasonography
We calculated the brain volumes of preterm infants using two-dimensional cranial ultrasonography and explored the relationships thereof with neurodevelopment.
- 18 December 2019
- Published by Springer Nature in Child's Nervous System
- Vol. 36 (6) , 1231-1237
Developmental outcomes of very low birthweight infants with non-hemorrhagic ventricular dilatations and the relationships thereof with absolute brain volumes measured via two-dimensional ultrasonography
We calculated the brain volumes of preterm infants using two-dimensional cranial ultrasonography and explored the relationships thereof with neurodevelopment.
- 26 May 2015
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 31 (2) , 170-176
School Performance and Neurodevelopment of Very Low Birth Weight Preterm Infants
Very low birth weight preterm infants are under significant risk of neurologic, developmental, and somatic problems. In this study, 90 infants born with a birth weight P = .042 and P = .026). Parents’ concern and presence of cognitive problems were correlated (P = .026). Environmental factors, as well as the prevention of morbidity, affected school performance positively.
- 26 May 2015
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 31 (2) , 170-176
School Performance and Neurodevelopment of Very Low Birth Weight Preterm Infants
Very low birth weight preterm infants are under significant risk of neurologic, developmental, and somatic problems. In this study, 90 infants born with a birth weight P = .042 and P = .026). Parents’ concern and presence of cognitive problems were correlated (P = .026). Environmental factors, as well as the prevention of morbidity, affected school performance positively.
- 28 January 2013
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 30 (10) , 857-862
Impact of Oral versus Intravenous Ibuprofen on Neurodevelopmental Outcome: A Randomized Controlled Parallel Study
Objective Although neurodevelopmental outcomes related to the management of patent ductus arteriosus with intravenous indomethacin and ibuprofen are known, little data on the long-term effects of oral ibuprofen can be found in the literature. Method A follow-up study of 99 infants with birth weight ≤ 1,500 g and gestational age ≤ 32 weeks who received either oral or intravenous ibuprofen for patent ductus arteriosus was conducted to assess at 18 to 24 months (corrected age), abnormal neurological, neurosensory, and cognitive impairment were defined as follows:neurological outcomes included moderate/severe cerebral palsy, neurosensory outcomes included bilateral hearing loss and blindness in either eye, and cognitive impairment included mental developmental index score < 70. Results The 18- to 24-month (corrected age) long-term outcomes of 30 subjects who received oral ibuprofen were compared with 27 subjects who received intravenous ibuprofen by certified and experienced examiners who were blind to the definitions of the groups. The results revealed that the long-term outcomes of the treatment regimens did not significantly differ. Conclusions Preterm infants who were treated with oral ibuprofen for patent ductus arteriosus had similar neurological, neurosensory, and cognitive outcomes to patients who received intravenous ibuprofen at 2 years of age.
- 28 January 2013
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 30 (10) , 857-862
Impact of Oral versus Intravenous Ibuprofen on Neurodevelopmental Outcome: A Randomized Controlled Parallel Study
Objective Although neurodevelopmental outcomes related to the management of patent ductus arteriosus with intravenous indomethacin and ibuprofen are known, little data on the long-term effects of oral ibuprofen can be found in the literature. Method A follow-up study of 99 infants with birth weight ≤ 1,500 g and gestational age ≤ 32 weeks who received either oral or intravenous ibuprofen for patent ductus arteriosus was conducted to assess at 18 to 24 months (corrected age), abnormal neurological, neurosensory, and cognitive impairment were defined as follows:neurological outcomes included moderate/severe cerebral palsy, neurosensory outcomes included bilateral hearing loss and blindness in either eye, and cognitive impairment included mental developmental index score < 70. Results The 18- to 24-month (corrected age) long-term outcomes of 30 subjects who received oral ibuprofen were compared with 27 subjects who received intravenous ibuprofen by certified and experienced examiners who were blind to the definitions of the groups. The results revealed that the long-term outcomes of the treatment regimens did not significantly differ. Conclusions Preterm infants who were treated with oral ibuprofen for patent ductus arteriosus had similar neurological, neurosensory, and cognitive outcomes to patients who received intravenous ibuprofen at 2 years of age.